Timo Soeterik

74 CHAPTER 4 18. Gandaglia G, Ploussard G, ValerioM, Mattei A, Fiori C, Roumiguie M, et al. The key combined value of multiparametric magnetic resonance imaging, and magnetic resonance imaging- targeted and concomitant systematic biopsies for the prediction of adverse pathological features in prostate cancer patients undergoing radical prostatectomy. Eur Urol . 2019. Online ahead of print. 19. Martini A, Gupta A, Lewis SC, et al. Development and internal validation of a side-specific, multiparametric mag-netic resonance imaging-based nomogram for the prediction of extracapsular extension of prostate cancer. BJU Int . 2018;122:1025–1033. 20. Nyarangi-Dix J, Wiesenfarth M, Bonekamp D, et al. Combined clinical parameters and multiparametric magnetic resonance imaging for the prediction of extraprostatic disease-A risk model for patient-tailored risk stratification when planning radical prostatectomy. Eur Urol Focus . 2018. Online ahead of print. 21. Ball MW, Partin AW, Epstein JI. Extent of extraprostatic extension independently influences biochemical recurrence- free survival: evidence for further pT3 subclassification. Urology . 2015;85:161–164. 22. Jeong BC, Chalfin HJ, Lee SB, et al. The relationship between the extent of extraprostatic extension and survival following radical prostatectomy. Eur Urol . 2015;67:342–346. 23. Ploussard G, Beauval JB, Lesourd M, et al. Added value of concomitant systematic biopsies for grade group prediction based on radical prostatectomy final pathology in magnetic resonance imaging positive cases undergoing fusion targeted biopsies. J Urol . 2019; 202:1182–1187.